Read More

BioLineRx Announces Publication In Nature Medicine Of Its GENESIS Phase 3 Clinical Trial Data Evaluating Motixafortide And G-CSF In Stem Cell Mobilization For Autologous Transplantation In Multiple Myeloma

- GENESIS trial achieved statistical significance (p<0.0001) across all primary and secondary endpoints - - Nature Medicine publication describes how GENESIS trial included patients representative of current